Richard Wilner

Company: Takeda

Job title: Head of Business Excellence & Sustainability, BioLife Plasma Services

Seminars:

Panel Discussion: Donor Selection for Best-in-Class Allogeneic Cell Therapy 9:00 am

Highlighting phenotypic considerations for donor-derived allogeneic cells Considering the manufacturing logistics of donor screening, and working with blood banks and centers to establish donor banks Commenting on the ethical considerations of profiting from a donor-derived productRead more

day: Gold-Star Donor Selection Focus Day